Simtuzumab Antibody
Simtuzumab is a humanized monoclonal antibody targeting LOXL2, investigated for treating primary sclerosing cholangitis (PSC) . Research in vitro and in animal models has explored its role in inhibiting fibrosis, though clinical trials showed it was not effective for advanced fibrosis in NASH.
Product Specifications
Product Name Alternative
Simtuzumab, LOXL2, Monoamine Oxidase, MonoamineOxidase, GS6624, GS-6624, GS 6624, AB 0024, AB0024, AB-0024
Target
Monoamine Oxidase
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience
Concentration
11.22 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
150.00 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6479326-01 0.1 mL
Guanylate Cyclase alpha-2, Soluble, CT (Guanylate Cyclase Soluble Subunit alpha-2, Guanylate Cyclase 1 Soluble alpha 2, GCS-alpha-2, GC-SA2, GUC1A2, GUCSA2, GUCY1A2) (MaxLight 490)
Sign In for Pricing
View Details MBS6479326-02 5x 0.1 mL
Guanylate Cyclase alpha-2, Soluble, CT (Guanylate Cyclase Soluble Subunit alpha-2, Guanylate Cyclase 1 Soluble alpha 2, GCS-alpha-2, GC-SA2, GUC1A2, GUCSA2, GUCY1A2) (MaxLight 490)
Sign In for Pricing
View Details